# Indo-cyanine Green (ICG) in Paediatric Oncology MIS

> **NCT04854018** · PHASE4 · COMPLETED · sponsor: **Birmingham Women's and Children's NHS Foundation Trust** · enrollment: 20 (actual)

## Conditions studied

- Pediatric Renal Tumor
- Metastatic Osteosarcoma
- Metastatic Ewing Sarcoma
- Pulmonary Metastasis
- Rhabdomyosarcoma
- Non-Rhabdo. Soft Tissue Sarcoma

## Interventions

- **DRUG:** Indocyanine green

## Key facts

- **NCT ID:** NCT04854018
- **Lead sponsor:** Birmingham Women's and Children's NHS Foundation Trust
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-04-30
- **Primary completion:** 2022-09-30
- **Final completion:** 2022-09-30
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2023-08-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04854018

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04854018, "Indo-cyanine Green (ICG) in Paediatric Oncology MIS". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04854018. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*